Biotech News
Vaxcyte to Present at the Guggenheim Emerging Outlook: Biotech Summit
investors.vaxcyte.com2026-05-06 14:45 EST
SAN CARLOS, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced that Company management will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit in New York on Thursday, February 12, 2026